バイオマニュファクチャリングにおけるウイルス検出・定量化市場：提供タイプ、技術、用途、エンドユーザー別-2025-2030年世界予測

バイオマニュファクチャリングにおけるウイルス検出・定量化市場は、2023年に26億7,000万米ドルと評価され、2024年には28億9,000万米ドルに達すると予測され、CAGR 8.40％で成長し、2030年には47億1,000万米ドルになると予測されています。

バイオ製造ウイルス検出・定量化市場は、バイオテクノロジー分野の重要なセグメントであり、バイオ医薬品製造の安全性と品質の確保に焦点を当てています。この市場には、PCR、ELISA、次世代シーケンシングなどの高度なバイオセンシング技術が含まれ、細胞培養や生物製剤中のウイルス汚染物質の検出と定量に極めて重要です。これらの技術の必要性は、特にワクチン、遺伝子治療、モノクローナル抗体の生産において、バイオセーフティと製品の有効性を保証する厳しい規制上の要求から生じています。アプリケーションは主に、正確なウイルス検出が重要である前臨床および商業的製造環境で発生します。主な成長要因には、急成長するバイオ医薬品業界、研究開発投資の増加、アッセイ開発における技術的進歩などがあり、迅速な検査法や自動化されたワークフローを革新する機会を企業に提供しています。予測分析におけるAIや機械学習の利用といった新たな動向は、高スループットで正確かつ経済的なソリューションに対する需要の高まりに対応するための有望な手段を提供します。

こうしたビジネスチャンスを生かすため、企業はマルチ病原体検出システムの開発と、効率と信頼性を高めるためのサンプル調製技術の強化に注力すべきです。しかし、高度な検出システムの高価格、標準化されたプロトコルの欠如、結果の解釈の複雑さなどの課題が、市場拡大の妨げになる可能性があります。規制上のハードルや技術的専門知識の必要性も大きな制約となります。しかし、共同研究開発やパートナーシップに投資することで、こうした障壁を緩和し、イノベーションと市場浸透を促進することができます。市場は、精度、スピード、費用対効果に焦点を当てたダイナミックな状況を呈しています。進化する規制基準や技術の進歩に適応しながら、利害関係者との強力な協力関係を維持する企業は、バイオ製造ウイルス検出・定量化という競争の激しい市場において、課題を効果的に克服し、成長機会を活用することができます。

市場力学：急速に進化するバイオマニュファクチャリングにおけるウイルス検出・定量化市場の主要市場インサイトを公開

バイオマニュファクチャリングにおけるウイルス検出・定量化市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ウイルス性疾患の発生率の増加と検出技術強化の必要性
  • 医薬品開発と製造プロセスへの投資の急増
  • ポータブルおよびポイントオブケアのバイタル検査に対する需要の高まり
• 市場抑制要因
  • 熟練者の不足と定量装置の高コスト
• 市場機会
  • ウイルス検査・定量法の急速な進歩
  • ウイルス汚染物質の環境モニタリングの重視
• 市場の課題
  • ウイルス量の分離に伴う技術的困難

ポーターのファイブフォース：バイオマニュファクチャリングにおけるウイルス検出・定量化市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオマニュファクチャリングにおけるウイルス検出・定量化市場における外部からの影響の把握

外部マクロ環境要因は、バイオマニュファクチャリングにおけるウイルス検出・定量化市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析バイオマニュファクチャリングにおけるウイルス検出・定量化市場における競合情勢の把握

バイオマニュファクチャリングにおけるウイルス検出・定量化市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスバイオマニュファクチャリングにおけるウイルス検出・定量化市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオマニュファクチャリングにおけるウイルス検出・定量化市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨バイオマニュファクチャリングにおけるウイルス検出・定量化市場における成功への道筋を描く

バイオマニュファクチャリングにおけるウイルス検出・定量化市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ウイルス性疾患の発生率増加と検出技術の強化の必要性
    • 医薬品開発と製造プロセスへの急激な投資
    • ポータブルおよびポイントオブケアのバイタルテストの需要増加
  • 抑制要因
    • 熟練した人材の不足と定量化装置の高コスト
  • 機会
    • ウイルス検査と定量化方法の急速な進歩
    • ウイルス汚染物質の環境モニタリングに重点を置く
  • 課題
    • ウイルス量の分離に関連する技術的な困難
• 市場セグメンテーション分析
  • 提供タイプ：高精度のための消耗品の進歩
  • 技術：PCR技術の採用を改善し、高い特異性を実現
  • アプリケーション：ワクチンおよび治療薬製造におけるアプリケーションの急増
  • エンドユーザー：CROおよびCDMOによるウイルス定量化の採用が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 バイオマニュファクチャリングにおけるウイルス検出・定量化市場提供タイプ別

• 消耗品
  • アクセサリー
  • キットとアッセイ
• 機器
• サービス

第7章 バイオマニュファクチャリングにおけるウイルス検出・定量化市場：技術別

• 酵素免疫測定法
• フローサイトメトリー
• プラークアッセイ
• ポリメラーゼ連鎖反応

第8章 バイオマニュファクチャリングにおけるウイルス検出・定量化市場：用途別

• 血液および血液製品製造
• 細胞・遺伝子治療製品の製造
• 幹細胞製品製造
• ティッシュおよびティッシュ製品製造
• ワクチンおよび治療薬製造

第9章 バイオマニュファクチャリングにおけるウイルス検出・定量化市場：エンドユーザー別

• CROとCDMO
• ライフサイエンス企業
• 試験所

第10章 南北アメリカのバイオマニュファクチャリングにおけるウイルス検出・定量化市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のバイオマニュファクチャリングにおけるウイルス検出・定量化市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのバイオマニュファクチャリングにおけるウイルス検出・定量化市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • 標的アレルゲン配列の信頼性の高い検出のためのDNAllergenリアルタイムPCRキットの発売
  • Virax Biolabs Group Limited、鳥インフルエンザAウイルスのリアルタイムPCR検査キットを発表
  • BGI Genomicsの新しい蛍光RT-PCRキットがオーストラリアでCOVID-19、インフルエンザ A型およびB型の検出に承認されました
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• BASF SE
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Charles River Laboratories
• Danaher Corporation
• Genscript Biotech Corporation
• Hamilton Company
• Illumina, Inc.
• LG Chem, Ltd.
• Lonza Group Ltd.
• Merck KGaA
• New England Biolabs
• Norgen Biotek Corp.
• Oxford Nanopore Technologies PLC
• PerkinElmer, Inc.
• Promega Corporation
• QIAGEN N.V.
• Recipharm AB
• Sartorius AG
• Shimadzu Corporation
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
• Thomas Scientific LLC
• Zymo Research Corporation

LIST OF FIGURES

• FIGURE 1. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET RESEARCH PROCESS
• FIGURE 2. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET DYNAMICS
• TABLE 7. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY PLAQUE ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY BLOOD & BLOOD PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CELLULAR & GENE THERAPY PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STEM CELL PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TISSUE & TISSUE PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY VACCINES & THERAPEUTICS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CROS & CDMOS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY LIFE SCIENCE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 47. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 73. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 74. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 78. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 79. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 164. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 165. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 166. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 183. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 184. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 185. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 188. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 189. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 190. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 238. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 239. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET, FPNV POSITIONING MATRIX, 2023

The Biomanufacturing Viral Detection & Quantification Market was valued at USD 2.67 billion in 2023, expected to reach USD 2.89 billion in 2024, and is projected to grow at a CAGR of 8.40%, to USD 4.71 billion by 2030.

The biomanufacturing viral detection and quantification market is a significant segment within the biotechnology sector, focusing on ensuring safety and quality in biopharmaceutical production. The scope encompasses advanced biosensing technologies, including PCR, ELISA, and next-generation sequencing, which are pivotal in detecting and quantifying viral contaminants in cell cultures and biologics. The necessity for these technologies arises from stringent regulatory demands ensuring biosafety and product efficacy, particularly in the production of vaccines, gene therapies, and monoclonal antibodies. Applications primarily occur in preclinical and commercial manufacturing settings, where accurate viral detection is crucial. Key growth factors include the burgeoning biopharmaceutical industry, increased R&D investments, and technological advancements in assay development, thus presenting opportunities for companies to innovate in rapid testing methods and automated workflows. Emerging trends such as the use of AI and machine learning in predictive analytics offer promising avenues for meeting the growing demand for high-throughput, accurate, and economical solutions.

To capitalize on these opportunities, businesses should focus on developing multi-pathogen detection systems and enhancing sample preparation techniques to increase efficiency and reliability. However, challenges such as the high cost of sophisticated detection systems, lack of standardized protocols, and complexity in interpreting results could impede market expansion. Regulatory hurdles and the need for technical expertise also pose significant constraints. Nonetheless, investing in collaborative R&D and partnerships can mitigate these barriers, fostering innovation and market penetration. The market presents a dynamic landscape with a focus on precision, speed, and cost-effectiveness. Companies that stay adaptable to evolving regulatory standards and technological advancements, while engaging in strong stakeholder collaborations, can effectively navigate challenges and leverage growth opportunities in the highly competitive market of biomanufacturing viral detection and quantification.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biomanufacturing Viral Detection & Quantification Market

The Biomanufacturing Viral Detection & Quantification Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence of viral diseases and need for enhanced detection techniques
  • Exponential investments in drug development and manufacturing processes
  • Growing demand for portable and point-of-care vital testing
• Market Restraints
  • Lack of skilled personnel and high cost of quantification devices
• Market Opportunities
  • Rapid advancements in viral testing and quantification methods
  • Emphasis on environmental monitoring of viral contaminants
• Market Challenges
  • Technical difficulties associated with the isolation of viral load

Porter's Five Forces: A Strategic Tool for Navigating the Biomanufacturing Viral Detection & Quantification Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biomanufacturing Viral Detection & Quantification Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biomanufacturing Viral Detection & Quantification Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biomanufacturing Viral Detection & Quantification Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biomanufacturing Viral Detection & Quantification Market

A detailed market share analysis in the Biomanufacturing Viral Detection & Quantification Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biomanufacturing Viral Detection & Quantification Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biomanufacturing Viral Detection & Quantification Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biomanufacturing Viral Detection & Quantification Market

A strategic analysis of the Biomanufacturing Viral Detection & Quantification Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biomanufacturing Viral Detection & Quantification Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BASF SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Charles River Laboratories, Danaher Corporation, Genscript Biotech Corporation, Hamilton Company, Illumina, Inc., LG Chem, Ltd., Lonza Group Ltd., Merck KGaA, New England Biolabs, Norgen Biotek Corp., Oxford Nanopore Technologies PLC, PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Recipharm AB, Sartorius AG, Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Thomas Scientific LLC, and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Biomanufacturing Viral Detection & Quantification Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Offering Type, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Accessories and Kits & Assays.
• Based on Technology, market is studied across Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Plaque Assay, and Polymerase Chain Reaction.
• Based on Application, market is studied across Blood & Blood Products Manufacturing, Cellular & Gene Therapy Products Manufacturing, Stem Cell Products Manufacturing, Tissue & Tissue Products Manufacturing, and Vaccines & Therapeutics Manufacturing.
• Based on End User, market is studied across CROs & CDMOs, Life Science Companies, and Testing Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of viral diseases and need for enhanced detection techniques
    • 5.1.1.2. Exponential investments in drug development and manufacturing processes
    • 5.1.1.3. Growing demand for portable and point-of-care vital testing
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of skilled personnel and high cost of quantification devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Rapid advancements in viral testing and quantification methods
    • 5.1.3.2. Emphasis on environmental monitoring of viral contaminants
  • 5.1.4. Challenges
    • 5.1.4.1. Technical difficulties associated with the isolation of viral load
• 5.2. Market Segmentation Analysis
  • 5.2.1. Offering Type: Advances in consumables for high accuracy
  • 5.2.2. Technology: Improved adoption of PCR technique for high specificity
  • 5.2.3. Application: Surging applications in vaccines & therapeutics manufacturing
  • 5.2.4. End User: Rising adoption from CROs and CDMOs for viral quantification
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biomanufacturing Viral Detection & Quantification Market, by Offering Type

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Accessories
  • 6.2.2. Kits & Assays
• 6.3. Instruments
• 6.4. Services

7. Biomanufacturing Viral Detection & Quantification Market, by Technology

• 7.1. Introduction
• 7.2. Enzyme-Linked Immunosorbent Assay
• 7.3. Flow Cytometry
• 7.4. Plaque Assay
• 7.5. Polymerase Chain Reaction

8. Biomanufacturing Viral Detection & Quantification Market, by Application

• 8.1. Introduction
• 8.2. Blood & Blood Products Manufacturing
• 8.3. Cellular & Gene Therapy Products Manufacturing
• 8.4. Stem Cell Products Manufacturing
• 8.5. Tissue & Tissue Products Manufacturing
• 8.6. Vaccines & Therapeutics Manufacturing

9. Biomanufacturing Viral Detection & Quantification Market, by End User

• 9.1. Introduction
• 9.2. CROs & CDMOs
• 9.3. Life Science Companies
• 9.4. Testing Laboratories

10. Americas Biomanufacturing Viral Detection & Quantification Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Biomanufacturing Viral Detection & Quantification Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Biomanufacturing Viral Detection & Quantification Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Launch of DNAllergen Real-time PCR Kits for the Reliable Detection Of Target Allergen Sequences
  • 13.3.2. Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit
  • 13.3.3. New BGI Genomics Fluorescent RT-PCR Kit Approved for COVID-19, Influenza A & B Detection in Australia
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. BASF SE
• 3. Becton, Dickinson and Company
• 4. Bio-Rad Laboratories, Inc.
• 5. bioMerieux SA
• 6. Charles River Laboratories
• 7. Danaher Corporation
• 8. Genscript Biotech Corporation
• 9. Hamilton Company
• 10. Illumina, Inc.
• 11. LG Chem, Ltd.
• 12. Lonza Group Ltd.
• 13. Merck KGaA
• 14. New England Biolabs
• 15. Norgen Biotek Corp.
• 16. Oxford Nanopore Technologies PLC
• 17. PerkinElmer, Inc.
• 18. Promega Corporation
• 19. QIAGEN N.V.
• 20. Recipharm AB
• 21. Sartorius AG
• 22. Shimadzu Corporation
• 23. Takara Bio Inc.
• 24. Thermo Fisher Scientific Inc.
• 25. Thomas Scientific LLC
• 26. Zymo Research Corporation